FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122311016> ?p ?o ?g. }

• W2122311016 endingPage "1424" @default.
• W2122311016 startingPage "1417" @default.
• W2122311016 abstract "Abstract Chronic inflammation has long been associated with neoplastic progression. Our group had recently shown that the addition of a large number of apoptotic tumor cells to the tumor microenvironment induces a potent acute inflammatory reaction capable of promoting melanoma growth; however, primarily necrotizing cells do not cause such a reaction. Here, we show that potent inflammatory agents, such as lipopolysaccharide (LPS) and carrageenan, also promote growth of subtumorigenic doses of melanoma cells, having no effect on melanoma proliferation in vitro. Inhibition of 5-lipoxygenase (5-LOX) seems to have a pivotal role in this model because caffeic acid and MK886, a FLAP (5-LOX–activating protein) inhibitor, partially hindered tumor growth induced by apoptotic cells or LPS. Other enzymes of the arachidonic acid pathway, cyclooxygenase-1 and cyclooxygenase-2, seem to have no participation in this tumor promoter effect, as the inhibitor of both enzymes (indomethacin) did not alter melanoma growth. Leukotriene B4 (LTB4), the main product of the 5-LOX pathway, was able to induce growth of subtumorigenic inocula of melanoma cells, and a LTB4 receptor antagonist inhibited acute inflammation-associated tumor growth. Addition to the tumor inflammatory microenvironment of eicosapentaenoic acid, an ω3-polyunsaturated fatty acid with anti-inflammatory properties, or leukotriene B5, an eicosapentaenoic acid–derived leukotriene, significantly inhibited tumor development. These results give new insights to the mechanisms through which inflammation may contribute to tumor progression and suggest that LOX has an important role in tumor progression associated with an inflammatory state in the presence of apoptosis, which may be a consideration for apoptosis-inducing treatments, such as chemotherapy and radiotherapy. (Mol Cancer Res 2009;7(9):1417–24)" @default.
• W2122311016 created "2016-06-24" @default.
• W2122311016 creator A5009905050 @default.
• W2122311016 creator A5028065032 @default.
• W2122311016 creator A5031520881 @default.
• W2122311016 creator A5047131106 @default.
• W2122311016 creator A5062080841 @default.
• W2122311016 creator A5065453303 @default.
• W2122311016 creator A5090809528 @default.
• W2122311016 date "2009-09-01" @default.
• W2122311016 modified "2023-10-18" @default.
• W2122311016 title "Leukotriene B4 Creates a Favorable Microenvironment for Murine Melanoma Growth" @default.
• W2122311016 cites W1508034450 @default.
• W2122311016 cites W1518237677 @default.
• W2122311016 cites W1518549789 @default.
• W2122311016 cites W1672565987 @default.
• W2122311016 cites W1782545213 @default.
• W2122311016 cites W1964662700 @default.
• W2122311016 cites W197577910 @default.
• W2122311016 cites W1992160817 @default.
• W2122311016 cites W1992932306 @default.
• W2122311016 cites W2000808749 @default.
• W2122311016 cites W2002127334 @default.
• W2122311016 cites W2004942960 @default.
• W2122311016 cites W2009718837 @default.
• W2122311016 cites W2012025441 @default.
• W2122311016 cites W2014167236 @default.
• W2122311016 cites W2019095153 @default.
• W2122311016 cites W2022437509 @default.
• W2122311016 cites W2024936447 @default.
• W2122311016 cites W2025695096 @default.
• W2122311016 cites W2030711913 @default.
• W2122311016 cites W2031084334 @default.
• W2122311016 cites W2036296180 @default.
• W2122311016 cites W2039599734 @default.
• W2122311016 cites W2040695321 @default.
• W2122311016 cites W2047898947 @default.
• W2122311016 cites W2048270768 @default.
• W2122311016 cites W2051648756 @default.
• W2122311016 cites W2055547672 @default.
• W2122311016 cites W2061062528 @default.
• W2122311016 cites W2067740832 @default.
• W2122311016 cites W2069428724 @default.
• W2122311016 cites W2072852488 @default.
• W2122311016 cites W2075131364 @default.
• W2122311016 cites W2076677873 @default.
• W2122311016 cites W2080854664 @default.
• W2122311016 cites W2081776165 @default.
• W2122311016 cites W2083552277 @default.
• W2122311016 cites W2089900609 @default.
• W2122311016 cites W2094521397 @default.
• W2122311016 cites W2095002823 @default.
• W2122311016 cites W2104383279 @default.
• W2122311016 cites W2118682325 @default.
• W2122311016 cites W2127130381 @default.
• W2122311016 cites W2131596612 @default.
• W2122311016 cites W2133439754 @default.
• W2122311016 cites W2139312815 @default.
• W2122311016 cites W2142438877 @default.
• W2122311016 cites W2145938006 @default.
• W2122311016 cites W2148828072 @default.
• W2122311016 cites W2149575514 @default.
• W2122311016 cites W2153703488 @default.
• W2122311016 cites W2161215993 @default.
• W2122311016 cites W2161508124 @default.
• W2122311016 cites W2164583400 @default.
• W2122311016 cites W2169945437 @default.
• W2122311016 cites W2626246102 @default.
• W2122311016 doi "https://doi.org/10.1158/1541-7786.mcr-09-0038" @default.
• W2122311016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19737966" @default.
• W2122311016 hasPublicationYear "2009" @default.
• W2122311016 type Work @default.
• W2122311016 sameAs 2122311016 @default.
• W2122311016 citedByCount "37" @default.
• W2122311016 countsByYear W21223110162012 @default.
• W2122311016 countsByYear W21223110162013 @default.
• W2122311016 countsByYear W21223110162014 @default.
• W2122311016 countsByYear W21223110162015 @default.
• W2122311016 countsByYear W21223110162016 @default.
• W2122311016 countsByYear W21223110162018 @default.
• W2122311016 countsByYear W21223110162019 @default.
• W2122311016 countsByYear W21223110162020 @default.
• W2122311016 countsByYear W21223110162021 @default.
• W2122311016 countsByYear W21223110162022 @default.
• W2122311016 countsByYear W21223110162023 @default.
• W2122311016 crossrefType "journal-article" @default.
• W2122311016 hasAuthorship W2122311016A5009905050 @default.
• W2122311016 hasAuthorship W2122311016A5028065032 @default.
• W2122311016 hasAuthorship W2122311016A5031520881 @default.
• W2122311016 hasAuthorship W2122311016A5047131106 @default.
• W2122311016 hasAuthorship W2122311016A5062080841 @default.
• W2122311016 hasAuthorship W2122311016A5065453303 @default.
• W2122311016 hasAuthorship W2122311016A5090809528 @default.
• W2122311016 hasBestOaLocation W21223110161 @default.
• W2122311016 hasConcept C104317684 @default.
• W2122311016 hasConcept C181199279 @default.
• W2122311016 hasConcept C185592680 @default.
• W2122311016 hasConcept C190283241 @default.

• next